Guariguata L, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–49.

Article  CAS  PubMed  Google Scholar 

Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–6.

Article  CAS  PubMed  Google Scholar 

Collaboration, N.C.D.R.F. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016; 387(10027):1513–1530.

Younossi ZM, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801.

Article  PubMed  Google Scholar 

Hu FB, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790–7.

Article  CAS  PubMed  Google Scholar 

Valderrabano RJ, Linares MI. Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification. Clin Diabetes Endocrinol. 2018;4:9.

Article  PubMed  PubMed Central  Google Scholar 

Schwartz AV, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305(21):2184–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Starup-Linde J, Hygum K, Langdahl BL. Skeletal Fragility in Type 2 Diabetes Mellitus. Endocrinol Metab (Seoul). 2018;33(3):339–51.

Article  CAS  PubMed  Google Scholar 

Hu Y, et al. Identification of novel variants associated with osteoporosis, type 2 diabetes and potentially pleiotropic loci using pleiotropic cFDR method. Bone. 2018;117:6–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen HL, Deng LL, Li JF. Prevalence of Osteoporosis and Its Associated Factors among Older Men with Type 2 Diabetes. Int J Endocrinol. 2013;2013:285729.

Article  PubMed  PubMed Central  Google Scholar 

Poiana C, Capatina C. Osteoporosis and Fracture Risk in Patients with Type 2 Diabetes Mellitus. Acta Endocrinol (Buchar). 2019;15(2):231–6.

Article  CAS  PubMed  Google Scholar 

Leidig-Bruckner G, et al. Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus. BMC Endocr Disord. 2014;14:33.

Article  PubMed  PubMed Central  Google Scholar 

Cosman F, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ala M, Jafari RM, Dehpour AR. Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes. Curr Diabetes Rev. 2020;16(9):984–1001.

Article  PubMed  Google Scholar 

Cozadd AJ, Schroder LK, Switzer JA. Fracture Risk Assessment: An Update. J Bone Joint Surg Am. 2021;103(13):1238–46.

Article  PubMed  Google Scholar 

Vestergaard P, Rejnmark L, Mosekilde L. Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int. 2005;16(2):134–41.

Article  PubMed  Google Scholar 

Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a meta-analysis. Osteoporos Int. 2007;18(4):427–44.

Article  CAS  PubMed  Google Scholar 

Komorita Y, et al. Impact of Body Weight Loss From Maximum Weight on Fragility Bone Fractures in Japanese Patients With Type 2 Diabetes: The Fukuoka Diabetes Registry. Diabetes Care. 2018;41(5):1061–7.

Article  CAS  PubMed  Google Scholar 

Monami M, et al. Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care. 2008;31(2):199–203.

Article  PubMed  Google Scholar 

Watts NB, et al. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2016;101(1):157–66.

Article  CAS  PubMed  Google Scholar 

Paschou SA, Vryonidou A. Diabetes mellitus and osteoporosis. Minerva Endocrinol. 2019;44(4):333–5.

PubMed  Google Scholar 

Maddaloni E, et al. Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes. J Endocrinol Invest. 2014;37(7):661–6.

Article  CAS  PubMed  Google Scholar 

Wen Y, et al. Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population. Front Endocrinol (Lausanne). 2021;12:531904.

Article  PubMed  Google Scholar 

Si Y, et al. Prevalence of Osteoporosis in Patients with Type 2 Diabetes Mellitus in the Chinese Mainland: A Systematic Review and Meta-Analysis. Iran J Public Health. 2019;48(7):1203–14.

PubMed  PubMed Central  Google Scholar 

Manley S. Haemoglobin A1c–a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med. 2003;41(9):1182–90.

Article  CAS  PubMed  Google Scholar 

Harding JL, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.

Article  PubMed  Google Scholar 

Huang Y, et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953.

Article  PubMed  PubMed Central  Google Scholar 

Khera R, et al. Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis. Gastroenterology. 2018;154(5):1309-1319.e7.

Article  PubMed  Google Scholar 

Škrha J, et al. Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord. 2016;17(1):103–10.

Article  PubMed  Google Scholar 

Cauley JA. Osteoporosis: fracture epidemiology update 2016. Curr Opin Rheumatol. 2017;29(2):150–6.

Article  PubMed  Google Scholar 

Little RR, Rohlfing CL. The long and winding road to optimal HbA1c measurement. Clin Chim Acta. 2013;418:63–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shan PF, et al. Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus. J Endocrinol Invest. 2011;34(3):190–6.

Article  CAS  PubMed  Google Scholar 

Tseng CH. Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus. Eur J Endocrinol. 2021;184(2):299–310.

Article  CAS  PubMed  Google Scholar 

Mu W, et al. Metformin promotes the proliferation and differentiation of murine preosteoblast by regulating the expression of sirt6 and oct4. Pharmacol Res. 2018;129:462–74.

Article  CAS  PubMed  Google Scholar 

Bennett WL, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011;154(9):602–13.

Article  PubMed  PubMed Central  Google Scholar